Fig. 2
From: Naringin attenuates angiotensin II induced cardiac hypertrophy by inhibiting carbonic anhydrase II
Concentration-dependent inhibition of CA-II by nutraceuticals (a) naringin, (b) acetazolamide, (c) naringenin and (d) quercetin. The decreased concentration of P-nitrophenol in the test reaction compared to control and enzyme activity reaction was expressed as percentage of CA-II inhibition. Data represents mean ± SEM (n = 3).
